ArticleHemaSphere2025

High-risk features of early relapse in newly-diagnosed multiple myeloma: The impact of cytogenetics and response to initial therapy.

Andrea Manubens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.